Use of MRJ in the follow-up of IL-4 mediated gene therapy of rat experimental gliomas

M. G. Bruzzone, S. Florio, S. Benedetti, F. Di Meco, N. Cirenei, B. Polio, L. Caposio, M. Cova, G. Finocchiaro, M. Savoiardo

Research output: Contribution to journalArticle

Abstract

Glioblastomas (GBL) constitute a relevant target for novel strategies of gene therapy. We previously suggested that gene transfer of interleukin 4 (IL-4) can complement therapies based on retroviral tranfer of the 'suicide' gene Herpes Simplex Virus- thymidine kinase (HSV-tk) and administration of ganciclovir (Benedetti et al, in press). To further define the efficacy of IL-4 alone or associated with HSV-tk-based therapies, we used MRJ for the follow-up of untreated C6 GBL grafted into rat brain by stereotactic techniques used as a control groups (n=9), or, treated with retroviral producer cells (RFC) expressing IL-4 (group A, n=14) or with IL-4 and HSV-tk RPC (group B, n=8 rats). In the 9 controls (survival after injection 23.5±1.9 days), mass effect, signal abnormalities and uptake of gadolinium DTPA were evident, six of 14 animals in group A (43%) and 4/8 in group B (50%) died during the first two months while 8/14 and 4/8, respectively, survived for at least 4 months. MRI demonstrated the presence of a large GBLin all cases at the first exsamination and the regression of the tumor in treated long-term survivors. These findings demonstrate the relevance of MRI for the follow-up of gene therapy of gliomas and, in agreement with survival data obtained in a larger group of animals not investigated by MRI, suggest that gene transfer of IL-4, by itself, can be very effective in the treatment of these malignancies.

Original languageEnglish (US)
Pages (from-to)41
Number of pages1
JournalItalian Journal of Neurological Sciences
Volume18
Issue number4
StatePublished - 1997
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Bruzzone, M. G., Florio, S., Benedetti, S., Di Meco, F., Cirenei, N., Polio, B., Caposio, L., Cova, M., Finocchiaro, G., & Savoiardo, M. (1997). Use of MRJ in the follow-up of IL-4 mediated gene therapy of rat experimental gliomas. Italian Journal of Neurological Sciences, 18(4), 41.